PAVmed Inc. (PAVM) stock
PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.32−0.19 (-12.58%)
Close on Nov 18, 2026Market cap $10.55MP/E –Yield –
PAVmed operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
PAVmed's operating income for the twelve months ending Jun 30, 2026 was -$26.70M. For fiscal 2025 it was -$21.81M. The highest annual figure on record is -$5.65M in fiscal 2016.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.81M | – |
| FY2024 | Dec 31, 2024 | -$44.49M | – |
| FY2023 | Dec 31, 2023 | -$68.80M | – |
| FY2022 | Dec 31, 2022 | -$91.09M | – |
| FY2021 | Dec 31, 2021 | -$54.39M | – |
| FY2020 | Dec 31, 2020 | -$23.35M | – |
| FY2019 | Dec 31, 2019 | -$14.30M | – |
| FY2018 | Dec 31, 2018 | -$10.56M | – |
| FY2017 | Dec 31, 2017 | -$8.03M | – |
| FY2016 | Dec 31, 2016 | -$5.65M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.02M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.04M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.80M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.84M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.72M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.45M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.19M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.58M | – |
| Q2 FY2024 | Jun 30, 2024 | -$13.68M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.04M | – |
| Q4 FY2023 | Dec 31, 2023 | -$16.38M | – |
| Q3 FY2023 | Sep 30, 2023 | -$15.53M | – |
| Q2 FY2023 | Jun 30, 2023 | -$16.48M | – |
| Q1 FY2023 | Mar 31, 2023 | -$20.40M | – |
| Q4 FY2022 | Dec 31, 2022 | -$24.60M | – |
| Q3 FY2022 | Sep 30, 2022 | -$23.37M | – |
| Q2 FY2022 | Jun 30, 2022 | -$23.48M | – |
| Q1 FY2022 | Mar 31, 2022 | -$19.64M | – |
| Q4 FY2021 | Dec 31, 2021 | -$19.68M | – |
| Q3 FY2021 | Sep 30, 2021 | -$13.67M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.97M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.08M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.56M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.53M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.01M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.25M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.59M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.24M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.32M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.14M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.31M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.57M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.74M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.94M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.89M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.97M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.02M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.16M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.71M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.93M | – |
See a number that looks wrong?